BioSpace News Archive

Deals

4BIO Capital leads Redpin Therapeutics’ $15.5 million Series A

4BIO Capital, an international venture capital firm focused solely on the advanced therapies sector, announces its investment in Redpin Therapeutics, Inc., a pioneering chemogenetics company developing drug-controlled gene therapies to address intractable diseases of the nervous system.

March 31, 2020
·
6 min read
Business

AstraZeneca to discover and develop siRNA therapeutics for Cardiovascular, Renal, Metabolic and Respiratory diseases in new collaboration

Collaboration with Silence Therapeutics aims to develop novel, targeted treatments to address significant unmet need

March 31, 2020
·
2 min read
Sartorius Supports the Development of the First Vaccine Candidate Against the Novel Coronavirus to Enter Clinical Trials

Sartorius has supported CanSino Biologics Inc. and Maj. Gen. Chen Wei’s team at the Institute of Bioengineering at the Academy of Military Medical Sciences in China in their development of the first vaccine candidate against the novel coronavirus SARS-CoV-2 to enter clinical trials.

March 31, 2020
·
2 min read
Business

Lilly and Sitryx Sign $880 Million+ 5-Year Development Deal

The two companies will work to develop up to four preclinical compounds discovered by Sitryx for autoimmune diseases.

March 31, 2020
·
3 min read
·
Mark Terry
Genetown

Genetown Hotbed: Churning Along During the COVID-19 Pandemic

As the biopharma industry responds to the COVID-19 pandemic, some of the area’s companies are at the very frontlines of drug development against the disease, while others play supporting roles for the entire industry. Here’s a look.

March 31, 2020
·
6 min read
·
Mark Terry
Biotech Beach

Amgen Update: No “Significant Delays” from COVID-19 Pandemic for KRAS Inhibitor

Like many biopharma companies, Amgen is evaluating how the COVID-19 pandemic is affecting its operations, supply chain and clinical trial programs.

March 31, 2020
·
2 min read
·
Mark Terry
Business

Charles River and Deciphex Strike Digital Pathology Deal

Under terms of the agreement, Charles River Laboratories will be able to provide its clients with the use of Deciphex’s flagship product.

March 31, 2020
·
2 min read
·
Alex Keown
Career Advice

4 Ways to Improve Your Productivity While Working From Home

Here are four ways to improve your productivity while working from home!

March 31, 2020
·
3 min read
·
Porschia Parker-Griffin
Business

Could a 100-Year-Old Tuberculosis Vaccine Help Prevent COVID-19?

Results from the trial, which will begin dosing on April 6, aren’t likely until September.

March 31, 2020
·
2 min read
·
Mark Terry
evitria Crosses 100-Citation Threshold

evitria AG, a global antibody expression service provider, announces that it has crossed the 100-citation threshold on Google Scholars.

March 31, 2020
·
1 min read